Evidence of enhanced type 2 immune response and impaired upregulation of a type 1 response in frail elderly nursing home residents
- 1 March 1997
- journal article
- Published by Elsevier in Mechanisms of Ageing and Development
- Vol. 94 (1-3) , 7-16
- https://doi.org/10.1016/s0047-6374(96)01821-0
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Cross-regulatory roles of interleukin (IL)-12 and IL-10 in atherosclerosis.Journal of Clinical Investigation, 1996
- Interleukin 12 at the site of disease in tuberculosis.Journal of Clinical Investigation, 1994
- Interleukin 10 (IL-10) inhibits human lymphocyte interferon gamma-production by suppressing natural killer cell stimulatory factor/IL-12 synthesis in accessory cells.The Journal of Experimental Medicine, 1993
- Response of aged versus young skin to intradermal administration of interferon gammaJournal of the American Academy of Dermatology, 1992
- Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression.The Journal of Experimental Medicine, 1991
- Pharmacologic Modulation of Picryl Chloride-Induced Contact Dermatitis in the MouseJournal of Investigative Dermatology, 1991
- Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones.The Journal of Experimental Medicine, 1989
- Immunology/Inflammation of the Skin—A 50-Year PerspectiveJournal of Investigative Dermatology, 1989
- Effector and suppressor circuits of the immune response are activated in vivo by different mechanisms.Proceedings of the National Academy of Sciences, 1987
- Modulation of cellular-immune responses in vivo and in vitro by histamine receptor-bearing lymphocytes.Journal of Clinical Investigation, 1976